Protein-Based Biomarkers in Blood Serum Could Classify Individuals With Alzheimer’s Disease

Home/Media Coverage/Protein-Based Biomarkers in Blood Serum Could Classify Individuals With Alzheimer’s Disease

Protein-Based Biomarkers in Blood Serum Could Classify Individuals With Alzheimer’s Disease

9.13.2010 Protein-Based Biomarkers in Blood Serum Could Classify Individuals With Alzheimer’s Disease
Archives of Neurology, JAMA
An initial analysis suggests that biomarkers in blood serum can be combined with clinical information to accurately classify patients with Alzheimer’s disease, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals.

2015-09-05T00:32:29+00:00 September 15th, 2010|Media Coverage|0 Comments

Leave A Comment

four + 13 =